Visual loss from aesthetic hyaluronic acid filler injections is an under-reported complication. Our study surveyed British Oculoplastic consultants and Consultant members of the British Eye Emergency Care Society, on their awareness of visual vascular complications of dermal fillers and its emergency management.
A prospective survey of the members of the British Oculoplastic Society and the British Eye Emergency Society, using the Survey Monkey platform.
There were 53 responses. Eighty five percent of responders were aware of ophthalmic artery occlusion and visual loss as a recognised complication of hyaluronic acid based fillers. Six respondents had encountered at least one case of visual loss associated with HA fillers. Approximately 27% of the respondents had some experience of the recommended appropriate management of this complication. Majority of these practitioners did not have local management guidelines for this complication (88%) nor were they aware of guidance to manage the complication (75%).
This survey captures the current experience of British Ophthalmologists and Oculoplastic Surgeons in the management of visual vascular complication with dermal fillers. This may relate to the rarity of this complication. Although there is an awareness of visual loss as a complication from aesthetic dermal fillers, there appears to be a lack of knowledge of current management guidelines across Eye Specialists in UK. It is important for practitioners to be able to recognise and manage vascular compromise and further study recommendations are made.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Fakih-Gomez N, Orte-Aldea MC, Poonja K, Khanna D. Hyaluronic Acid Filler Emergency Kit. Am J Cosmet Surg. 2019;118:71–6.
King M, Convery C, Davies E. This monthʼs guideline: The Use of Hyaluronidase in Aesthetic Practice. J Clin Aesthet Dermatol. 2018;11:E61–8.
Hirsch RJ, Brody HJ, Carruthers JDA. Hyaluronidase in the office: a necessity for every dermasurgeon that injects HA. J Cosmet Laser Ther. 2007;9:182–5.
Park SW, Woo SJ, Park KH, Huh JA, Jung C, Kwong OK. Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections. Am J Ophthalmol. 2012;154:653–62.
Park KH, Kim YK, Woo SJ, Kang SJ, Lee WK, Korean Retina Society. Iatrogenic occlusion of the ophthalmic artery after cosmetic facial filler injections: a national survey by the Korean Retina Society. JAMA Ophthalmol. 2014;132:714–23.
Zhu GZ, Sun ZS, Liao WX, Cai B, Chen CL, Zheng HH, et al. Efficacy of retrobulbar hyaluronidase injection for vision loss resulting from hyaluronic acid filler embolization. Aesthetic Surg J. 2017;38:12–22.
Myung Y, Yim S, Jeong JH, Kim BK, Heo CY, Baek RM, et al. The classification and prognosis of periocular complications related to blindness following cosmetic filler injection. Plast Recon Surg. 2017;140:61–4.
Lazzeri D, Agonstini T, Figus M, Nardi M, Pantaloni M, Lazzeri S. Blindness following cosmetic injection of the face. Plast Reconstructive Surg. 2012;129:995–1012.
Humzah MD, Ataullah S, Chiang C, Malhotra R, Goldberg R. The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): a consensus on practical guidance. J Cosmet Dermatol. 2019;18:71–6.
von Bahr G. Multiple embolisms in the fundus of an eye after an injection in the scalp. Acta Ophthalmol (Copenh). 1963;41:85–91.
Belezany K, Carruthers JDA, Humphrey S, Jones DJ. Avoiding and treating blindness from fillers: a review of the world literature. Dermatologic Surg. 2015;41:1097–117.
Loh KTD, Chua JJ. Prevention and management of vision loss relating to facial filler injections. Singap Med J. 2016;57:438–43.
Cohen JL, Biesman BS, Dayan SH, DeLorenzi C, Lambros VS, Nestor MS, et al. Treatment of hyaluronic acid filler-induced impending necrosis wth hyaluronidase: consensus recommendations. Aesthet Surg J. 2015;35:844–9.
Beleznay K, Humphrey S, Carruthers J, Alastair C. Vascular compromise from soft tissue augmentation. J Clin Aesthetic Dermatol. 2014;7:6.
Chen Y, Wang W, Li J, Yu Y, Li L, Lu N. Fundus artery occlusion caused by cosmetic facial injections. Chin Med J. 2014;127:1434–7.
Carruthers J, Fagien S, Dolman P. Retro or Peri Bulbar injection techniques reverse visual loss after filler injections. Dermatol Surg. 2015;41(suppl 1):S354–7.
Fagien S, Carruthers J. Commentary on restoration of visual loss with retrobulbar hyaluronidase injection after hyaluronic acid filler. Dermatol Surg. 2018;44:437–43.
Chesnut C. Restoration of visual loss with retrobulbar hyaluronidase injection after hyaluronic acid filler. Dermatol Surg. 2018;44:435–7.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Joganathan, V., Shah-Desai, S. Awareness of management of hyaluronic acid induced visual loss: A British National Survey. Eye 34, 2280–2283 (2020). https://doi.org/10.1038/s41433-020-0810-7